Irritable Bowel Syndrome Clinical Trial
Official title:
GUT-FOCUSED GROUP HYPNOSIS FOR TREATMENT OF IRRITABLE BOWEL SYNDROME - A RANDOMISED CONTROLLED TRIAL
This randomised controlled trial (RCT) aimed at assessing the efficacy of hypnotherapy in group sessions (GHT) with a 12-months follow-up.
Method:Patients with IBS, fulfilling Rome III criteria, and aged between 18 and 70, were
recruited from the University Hospital of Vienna, from primary care physicians and the
Austrian IBS patients' organisation by an information letter with an invitation to
participate in this RCT. Patients were invited for an interview at the University hospital
to confirm the IBS diagnosis according to the guidelines. Exclusion criteria were:
pregnancy, bowel surgery, mental retardation, insufficient knowledge of German, a
concomitant severe organic and/or psychiatric disease, and recently indicated treatment with
anti-depressants. Anti-depressants at a stable dose for longer than three months were
allowed for admission to the study. The time for patients to reach the hospital was not to
be longer than one hour. Patients with lactose and fructose intolerance as diagnosed by
breath tests were not excluded if they had had an adequate diet over a period of more than
three weeks without any change of their IBS symptoms.
Randomisation and therapy If 12 patients fulfilled all inclusion criteria they were randomly
assigned to one of the two study arms at a 1:1 ratio. Randomisation was done by using
permutated blocks of four in order to provide a balanced allocation. The investigator who
generated the randomisation schedule was independent of the rest of the trial (blinded).
Randomisation was either to supportive talks and symptomatic (standard) medical treatment
(SMT, IBS-symptom-related) according to the guidelines (15-17) or to GHT with SMT. The GHT
protocol used was the Manchester protocol of gut-directed hypnotherapy ( ) and consisted of
10 weekly sessions (45 minutes) with six patients per group over a treatment period of 12
weeks. GHT was performed at the University Hospital by two experienced physicians, trained
in Manchester (UK). At the first session patients were informed about effects of hypnosis
and at the third session subjects were given a compact disc (created by hypnotherapists) for
practicing at home on a daily basis (practicing was documented). After an induction of
hypnosis by closing the eyes a combination of standard deepening procedures followed. Then
suggestions for ego-strengthening, power of self-control and gut-specific relaxation were
made with hands on abdomen and visualization of slow, rhythmic waves (water, sea, or river)
in pleasant, relaxing situations. The final phase involved imagery to increase one's sense
of control and self-efficacy over IBS symptoms. GHT patients received also SMT. For control
patients the same frequency and duration (45 minutes, SMT) of doctor's visits were offered
at the University Hospital provided by a physician with additional qualification in
psychosomatic medicine. No kind of relaxation techniques was allowed for control patients
during the study. Psychotherapies and (changes of) symptomatic medication were allowed for
all patients if indicated. If anti-depressants were taken at a stable dose at baseline, no
dose reduction or increase was allowed until the six-month follow-up.
All data were collected by study coordinators not involved in the treatment. Data were
entered into SPSS 17.0 and analysed by an independent person with no information about
patients' randomisation (blinded).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
| Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
| Completed |
NCT05213910 -
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
|
N/A | |
| Recruiting |
NCT05985018 -
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
|
N/A | |
| Completed |
NCT04486469 -
Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study.
|
N/A | |
| Completed |
NCT06407609 -
Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS
|
N/A | |
| Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
| Completed |
NCT04145856 -
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico
|
Phase 4 | |
| Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
| Active, not recruiting |
NCT03586622 -
One Year Home Monitoring and Treatment of IBS Patients
|
N/A | |
| Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
| Not yet recruiting |
NCT06369753 -
Visible Abdominal Distension
|
N/A | |
| Not yet recruiting |
NCT05157867 -
In Vivo Effects of Amylase Trypsin Inhibitors
|
N/A | |
| Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
| Recruiting |
NCT05001997 -
Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT02953171 -
Probiotics in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT02977975 -
Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
| Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 | |
| Completed |
NCT02980406 -
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
|
N/A |